Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Homology Medicines Inc (FIXX)
NASDAQ:FIXX
Homology Medicines (FIXX) Stock Price & Analysis
671 Followers
FIXX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.90 - $3.31
Previous Close$0.91
Volume279.99K
Average Volume (3M)160.06K
Market Cap
$52.49M
Enterprise Value-$93.06M
Total Cash (Recent Filing)$175.03M
Total Debt (Recent Filing)$29.48M
Price to Earnings (P/E)-9.2
Beta0.91
Next Earnings
May 15, 2023EPS Estimate
-$0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding57,678,435
10 Day Avg. Volume369,912
30 Day Avg. Volume160,056
Standard Deviation0.18
R-Squared0.00005
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.29
Price to Sales (P/S)16.36
Price to Cash Flow (P/CF)57.40
P/FCF Ratio3.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-29.01
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.71
Forecast
1Y Price Target
$9.20Price Target Upside910.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Homology Medicines News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
FIXX FAQ
What was Homology Medicines Inc’s price range in the past 12 months?
Homology Medicines Inc lowest stock price was $0.90 and its highest was $3.31 in the past 12 months.
What is Homology Medicines Inc’s market cap?
Currently, no data Available
When is Homology Medicines Inc’s upcoming earnings report date?
Homology Medicines Inc’s upcoming earnings report date is May 15, 2023 which is in 49 days.
How were Homology Medicines Inc’s earnings last quarter?
Homology Medicines Inc released its earnings results on Mar 09, 2023. The company reported -$0.6 earnings per share for the quarter, missing the consensus estimate of -$0.492 by -$0.108.
Is Homology Medicines Inc overvalued?
According to Wall Street analysts Homology Medicines Inc’s price is currently Undervalued.
Does Homology Medicines Inc pay dividends?
Homology Medicines Inc does not currently pay dividends.
What is Homology Medicines Inc’s EPS estimate?
Homology Medicines Inc’s EPS estimate is -$0.53.
How many shares outstanding does Homology Medicines Inc have?
Homology Medicines Inc has 57,678,436 shares outstanding.
What happened to Homology Medicines Inc’s price movement after its last earnings report?
Homology Medicines Inc reported an EPS of -$0.6 in its last earnings report, missing expectations of -$0.492. Following the earnings report the stock price went down -8.209%.
Which hedge fund is a major shareholder of Homology Medicines Inc?
Among the largest hedge funds holding Homology Medicines Inc’s share is Caxton Associates LP. It holds Homology Medicines Inc’s shares valued at N/A.
---
Homology Medicines Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.20 (910.99% Upside)
$9.20 (910.99% Upside)
Hedge Fund Trend
Decreased
By 175.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 3.0%
Last 30 Days ▲ 3.0%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-71.73%
12-Months-Change
Fundamentals
Return on Equity
-2.88%
Trailing 12-Months
Asset Growth
7.91%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Homology Medicines Inc
Homology Medicines, Inc. operates as a technology platform to design and develop treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.
---
Top 5 ETFs holding FIXX
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold FIXX. The ETFs are listed according to market value of FIXX within the ETF
---
vTv Therapeutics
―
Viracta Therapeutics
―
Verastem
―
MiNK Therapeutics
―
Immune Therapeutics
―
---